KRT (Karat Packaging Inc. Common Stock) Stock Analysis - Politician Trades

Karat Packaging Inc. Common Stock (KRT) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, KRT trades at $27.12 with a market cap of $548.20M and a P/E ratio of 17.39. KRT moved +2.37% today. Year to date, KRT is +21.16%; over the trailing twelve months it is -11.00%. Its 52-week range spans $20.61 to $33.89. Analyst consensus is neutral with an average price target of $31.50. Rallies surfaces KRT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded KRT stock?

Rallies tracks politician and congressional stock disclosures for KRT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

KRT Key Metrics

Key financial metrics for KRT
MetricValue
Price$27.12
Market Cap$548.20M
P/E Ratio17.39
EPS$1.59
Dividend Yield0.45%
52-Week High$33.89
52-Week Low$20.61
Volume47
Avg Volume0
Revenue (TTM)$481.07M
Net Income$32.99M
Gross Margin35.94%

Latest KRT News

Recent KRT Insider Trades

  • Guo Jian bought 1.36K (~$30.09K) on Nov 12, 2025.
  • Yu Alan sold 112.50K (~$3.04M) on Jun 27, 2025.
  • Cheng Marvin sold 112.50K (~$3.04M) on Jun 27, 2025.

KRT Analyst Consensus

3 analysts cover KRT: 0 strong buy, 1 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $31.50.

Common questions about KRT

Which politicians traded KRT stock?
Rallies tracks politician and congressional stock disclosures for KRT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in KRT?
Yes. Rallies tracks politician and congressional stock disclosures for KRT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is KRT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KRT. It does not provide personalized investment advice.
KRT

KRT